» Articles » PMID: 39114902

Impact of Hypertension on the Dose-Response Association Between Physical Activity and Stroke: A Cohort Study

Overview
Journal Stroke
Date 2024 Aug 8
PMID 39114902
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Regular physical activity is associated with a reduced stroke risk. However, this relationship might be attenuated in the presence of hypertension and antihypertensive medication use. We examined the dose-response relationship between physical activity and stroke in normotensive and hypertensive individuals.

Methods: A Dutch population-based cohort including 139 930 individuals (41% men; mean age, 44±13) was performed (median follow-up, 6.75 years). Participants were stratified at baseline as hypertensive (44%) or normotensive (56%) and categorized into quartiles of the lowest (Q1) to the highest (Q4) moderate-to-vigorous, self-reported physical activity. The primary outcome was incident stroke (fatal and nonfatal). Cox regression estimated hazard ratios and 95% CIs. The main analyses were stratified on baseline blood pressure and adjusted for confounders. Hypertensives were stratified into medicated (21%) or non-medicated (79%).

Results: Compared with Q1, adjusted hazard ratios were 0.87 (0.69-1.10; =0.23), 0.75 (0.59-0.95; =0.02), and 0.94 (0.74-1.20; =0.64) for Q2 to Q4, respectively in the total population. Hazard ratios for normotensives were 0.79 (0.50-1.25; =0.32), 0.75 (0.48-1.18; =0.22), 0.97 (0.62-1.51; =0.90) for Q2 to Q4, respectively. In hypertensives, hazard ratios were 0.89 (0.68-1.17; =0.41), 0.74 (0.56-0.98; =0.03), 0.92 (0.69-1.23; =0.56) for Q2 to Q4, respectively. There was no significant interaction between hypertension status for the relation between physical activity and stroke risk. The stratified analysis revealed a smaller benefit of moderate-to-vigorous physical activity in medicated hypertensives compared with nonmedicated hypertensives, but no significant interaction effect was found.

Conclusions: Regular moderate-to-vigorous physical activity is beneficial for stroke risk reduction (Q3 compared with Q1), which is not affected by hypertension. Antihypertensive medication may be associated with a smaller benefit of moderate-to-vigorous physical activity on the risk of stroke, but further research is warranted.

Citing Articles

Exercise intensity and mortality in overweight and obese patients with chronic kidney disease: longitudinal analysis (1999-2016).

Qian C, Zhou F, Lu D, Huang J, Sun M BMC Public Health. 2024; 24(1):3020.

PMID: 39482632 PMC: 11529189. DOI: 10.1186/s12889-024-20498-6.

References
1.
Ainsworth B, Haskell W, Herrmann S, Meckes N, Bassett Jr D, Tudor-Locke C . 2011 Compendium of Physical Activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011; 43(8):1575-81. DOI: 10.1249/MSS.0b013e31821ece12. View

2.
Ding D, Lawson K, Kolbe-Alexander T, Finkelstein E, Katzmarzyk P, van Mechelen W . The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet. 2016; 388(10051):1311-24. DOI: 10.1016/S0140-6736(16)30383-X. View

3.
Sjurdarson T, Bejder J, Andersen A, Bonne T, Kyhl K, Roin T . Effect of angiotensin-converting enzyme inhibition on cardiovascular adaptation to exercise training. Physiol Rep. 2022; 10(13):e15382. PMC: 9277514. DOI: 10.14814/phy2.15382. View

4.
Van Poppel M, Chinapaw M, Mokkink L, van Mechelen W, Terwee C . Physical activity questionnaires for adults: a systematic review of measurement properties. Sports Med. 2010; 40(7):565-600. DOI: 10.2165/11531930-000000000-00000. View

5.
Ekelund U, Tarp J, Steene-Johannessen J, Hansen B, Jefferis B, Fagerland M . Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis. BMJ. 2019; 366:l4570. PMC: 6699591. DOI: 10.1136/bmj.l4570. View